Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota

Ophthalmology

Volumn 106, Issue 4, 1999, Pages 746-750

  Cook Jr , Briggs E ^a   Bartley, George B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CHEMOSURGERY; CURETTAGE; DISEASE COURSE; EYELID RECONSTRUCTION; EYELID TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UNITED STATES;

EID: 12944270573     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90161-6     Document Type: Article

References (27)

1. Welch RB, Duke JR. Lesions of the lids: a statistical note. Am J Ophthalmol 1958;45:415-6.
2. Aurora AL, Blodi FC. Lesions of the eyelids: a clinicopathological study. Surv Ophthalmol 1970;15:94-104.
3. Tesluk GC. Eyelid lesions: incidence and comparison of benign and malignant lesions. Ann Ophthalmol 1985;17:704-7.
4. Percy C, Young JL Jr, Muir C, et al. Cancer. Introduction. Cancer 1995; 75(1 Suppl):140-6.
5. Bartley GB. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 1994;92:477-588.
6. Kurland LT, Elveback LR, Nobrega FT. Population studies in Rochester and Olmsted County, Minnesota, 1900-1968. In: Kessler II, Levin ML, eds. The Community as an Epidemiologic Laboratory; A Casebook of Community Studies. Baltimore: Johns Hopkins Press, 1970;47-70.
7. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54-63.
8. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958;53:457-81.
10. Bergstralh EJ, Offord KP, Chu CP, et al. Calculating incidence, prevalence and mortality rates for Olmsted County, Minnesota: an update. In: Technical Report Series No. 49. Section of Biostatistics, Mayo Clinic, Rochester, Minnesota, 1993.
11. Woods JE, Farrow GM. Peripheral tissue examination for malignant lesions of the skin. Mayo Clin Proc 1991;66:207-9.
12. Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993;38:169-92.
13. Reifler DM, Hornblass A. Squamous cell carcinoma of the eyelid. Surv Ophthalmol 1986;30:349-65.
14. Margo CE, Mulla ZD. Malignant tumors of the eyelid: a population-based study of non-basal cell and non-squamous cell malignant neoplasms. Arch Ophthalmol 1998;116:195-8.
15. Lober CW, Fenske NA. Basal cell, squamous cell, and sebaceous gland carcinomas of the periorbital region. J Am Acad Dermatol 1991;25:685-90.
16. Leshin B, Yeatts P, Anscher M, et al. Management of periocular basal cell carcinoma: Mohs' micrographic surgery versus radiotherapy. Surv Ophthalmol 1993;38:193-212.
17. Roenigk RK. Mohs' micrographic surgery. Mayo Clin Proc 1988;63:175-83.
18. Kwitko ML, Boniuk M, Zimmerman LE. Eyelid tumors with reference to lesions confused with squamous cell carcinoma. I. Incidence and errors in diagnosis. Arch Ophthalmol 1963;69: 693-7.
19. Doxanas MT, Iliff WJ, Iliff NT, Green WR. Squamous cell carcinoma of the eyelids. Ophthalmology 1987;94:538-41.
20. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
21. Gilchrest BA, Garmyn M, Yaar M. Aging and photoaging affect gene expression in cultured human keratinocytes. Arch Dermatol 1994;130:82-6.
22. Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 1974;34:1333-8.
23. Swanbeck G, Hillström L. Analysis of etiological factors of squamous cell skin cancer of different locations. 4. Concluding remarks. Acta Derm Venereol 1971;51:151-6.
24. Vitaliano PP, Urbach F. The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol 1980;116:454-6.
25. Abraham JC, Jabaley ME, Hoopes JE. Basal cell carcinoma of the medial canthal region. Am J Surg 1973;126:492-5.
26. Payne JW, Duke JR, Butner R, Eifrig DE. Basal cell carcinoma of the eyelids. A long-term follow-up study. Arch Ophthalmol 1969;81:553-8.
27. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 1996; 125:815-21.